Literature DB >> 9866007

Women's preferences for vaginal antimicrobial contraceptives. III. Choice of a formulation, applicator, and packaging.

E Hardy1, A L Jiménez, K S de Pádua, L J Zaneveld.   

Abstract

Novel vaginal formulations are under development to combat the increasing incidence of sexually transmitted diseases, including AIDS, and also unplanned pregnancies. A study was performed to determine women's preferences for different dosage forms (gel, cream, ovule/suppository, film, foam, tablet), width, length, and color of an applicator, and various types of packages. The study was conducted in Campinas, Brazil. A total of 635 women were interviewed, including both adolescents and adults and low and middle-high socioeconomic groups. The large majority of the women preferred a gel over a cream; both were preferred over the other methods. When asked which method they would not use, the film was most frequently identified, followed by the tablet and ovule. The primary reasons for selecting a particular dosage form were ease of use, absence of odor or the presence of a pleasant one, absence of color, and insertion with an applicator. The major reasons for not using a method were discomfort, "plastic" appearance, distrust of effectiveness, difficulty with insertion, messiness, and rigidity/hardness. The majority of the women liked the applicator shown. The prefilled single dose applicator was by far the preferred packaging. This information should aid in the development of consumer-friendly, vaginal formulations.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9866007     DOI: 10.1016/s0010-7824(98)00104-8

Source DB:  PubMed          Journal:  Contraception        ISSN: 0010-7824            Impact factor:   3.375


  23 in total

Review 1.  Improving topical microbicide applicators for use in resource-poor settings.

Authors:  Janet G Vail; Jessica A Cohen; Kimberly L Kelly
Journal:  Am J Public Health       Date:  2004-07       Impact factor: 9.308

2.  Willingness to use microbicides is affected by the importance of product characteristics, use parameters, and protective properties.

Authors:  Kathleen M Morrow; Joseph L Fava; Rochelle K Rosen; Sara Vargas; Candelaria Barroso; Anna L Christensen; Cynthia Woodsong; Lawrence Severy
Journal:  J Acquir Immune Defic Syndr       Date:  2007-05-01       Impact factor: 3.731

3.  Fluid bed drying of guarana (Paullinia cupana HBK) extract: effect of process factors on caffeine content.

Authors:  Renata S Pagliarussi; Jairo K Bastos; Luis A P Freitas
Journal:  AAPS PharmSciTech       Date:  2006-06-16       Impact factor: 3.246

Review 4.  Vaginal drug delivery systems for HIV prevention.

Authors:  Lisa Cencia Rohan; Alexandra B Sassi
Journal:  AAPS J       Date:  2009-02-05       Impact factor: 4.009

Review 5.  Development of topical microbicides to prevent the sexual transmission of HIV.

Authors:  Robert W Buckheit; Karen M Watson; Kathleen M Morrow; Anthony S Ham
Journal:  Antiviral Res       Date:  2009-10-27       Impact factor: 5.970

6.  Modified silicone elastomer vaginal gels for sustained release of antiretroviral HIV microbicides.

Authors:  Claire J Forbes; Clare F McCoy; Diarmaid J Murphy; A David Woolfson; John P Moore; Abbey Evans; Robin J Shattock; R Karl Malcolm
Journal:  J Pharm Sci       Date:  2014-03-01       Impact factor: 3.534

7.  Preferred Physical Characteristics of Vaginal Film Microbicides for HIV Prevention in Pittsburgh Women.

Authors:  Maria D Fan; Lindsay F Kramzer; Sharon L Hillier; Judy C Chang; Leslie A Meyn; Lisa C Rohan
Journal:  Arch Sex Behav       Date:  2016-08-29

8.  Predictors of using a microbicide-like product among adolescent girls.

Authors:  Mary B Short; Paul A Succop; Ana M Ugueto; Susan L Rosenthal
Journal:  J Adolesc Health       Date:  2007-07-20       Impact factor: 5.012

Review 9.  The vagina as a route for drug delivery: a review.

Authors:  Sushma Srikrishna; Linda Cardozo
Journal:  Int Urogynecol J       Date:  2012-12-11       Impact factor: 2.894

10.  High-risk women's willingness to try a simulated vaginal microbicide: results from a pilot study.

Authors:  Katie E Mosack; Margaret R Weeks; Laurie Novick Sylla; Maryann Abbott
Journal:  Women Health       Date:  2005
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.